Aptinyx Announces Results of Phase 2 Fibromyalgia Study of NYX-2925 Have Been Selected for Late-Breaking Presentation at the American College of Rheumatology Annual Meeting

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs

Brenda Snow
Authentic Patient Voice

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence

Daniel Sontupe
Market Access

Matthew Durham
Omnidynamic Marketing

Matt Turner
Patient Affordability

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling